Collaborative Care in Myelofibrosis: Clinical Commentary Evaluation (ID: i882-2)

Question Title

* 1. What is your degree?

MD/DO

Other (please specify)

Question Title

* 2. What is your specialty?

Medical Oncology

Hematology

Other (please specify)

Question Title

* 3. Which of the following best describes your practice setting?

Academic medical center

Community hospital

Group practice

VA/DOD/Government

Other (please specify)

Question Title

* 4. How many patients with myelofibrosis do you see in a typical week?

1 to 10

11 to 25

26 to 50

More than 50

Question Title

* 5. How many years have you been in practice?

1 to 10

11 to 20

>20

Question Title

* 6. Please rate your level of agreement by checking the appropriate rating. The educational activity:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Met the stated learning objectives	Met the stated learning objectives Strongly agree	Met the stated learning objectives Agree	Met the stated learning objectives Neutral	Met the stated learning objectives Disagree	Met the stated learning objectives Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Was effectively delivered by faculty	Was effectively delivered by faculty Strongly agree	Was effectively delivered by faculty Agree	Was effectively delivered by faculty Neutral	Was effectively delivered by faculty Disagree	Was effectively delivered by faculty Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I will apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 8. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason.

Question Title

* 9. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Increase or start using risk stratification scoring for patients across lines of treatment

Utilize prognostic scoring to identify higher risk patients

Recognize the connection between higher risk prognostic scores and survival and treat accordingly

Increased ability to select and apply the appropriate risk stratification scoring system

Explain treatment recommendations to patients utilizing details from the supporting clinical trial information

Compare new and emerging agents for patients with anemia and myelofibrosis

Recognize the quality of life burden associated with transfusion dependence or severe anemia

Identify the appropriate treatment for patients with myelofibrosis and anemia

Prioritize the most clinically significant symptomology of myelofibrosis

Other (please specify)

Question Title

* 10. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 11. As a result of your participation in this activity, what is one change you are most likely to implement in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for myelofibrosis:

Question Title

* 1. What is your degree?

Question Title

* 2. What is your specialty?

Question Title

* 3. Which of the following best describes your practice setting?

Question Title

* 4. How many patients with myelofibrosis do you see in a typical week?

Question Title

* 5. How many years have you been in practice?

Question Title

* 6. Please rate your level of agreement by checking the appropriate rating. The educational activity:

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

Question Title

* 8. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 9. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 10. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 11. As a result of your participation in this activity, what is one change you are most likely to implement in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for myelofibrosis:

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe: